EKF Diagnostics (LON:EKF) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell?

EKF Diagnostics Holdings plc (LON:EKF) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 25.35 and traded as high as GBX 26.90. EKF Diagnostics shares last traded at GBX 26.50, with a volume of 110,948 shares changing hands.

Analysts Set New Price Targets

Separately, Stifel Nicolaus reaffirmed a “buy” rating and set a GBX 35 price objective on shares of EKF Diagnostics in a research note on Wednesday, April 22nd. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of GBX 35.

EKF Diagnostics Trading Up 0.9%

The business has a 50 day simple moving average of GBX 25.31 and a 200-day simple moving average of GBX 25.37. The company has a current ratio of 4.16, a quick ratio of 1.77 and a debt-to-equity ratio of 2.01. The stock has a market capitalization of £114.66 million, a price-to-earnings ratio of 56.67 and a beta of 0.53.

EKF Diagnostics (LON:EKF) last released its quarterly earnings data on Tuesday, March 24th. The company reported GBX 0.47 EPS for the quarter. EKF Diagnostics had a return on equity of 3.01% and a net margin of 4.12%. On average, equities analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.